Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Background There has been limited data on anticoagulation strategies and long-term
recurrence in patients with venous thromboembolism (VTE) in the era of direct oral …

Venous thromboembolism (VTE) is a common condition that can recur, leading to multiple
therapeutic strategies to prevent it. The aim of this study was to explore the clinical efficacy of …

Background Venous thromboembolism (VTE), encompassing both deep vein thrombosis
(DVT) and pulmonary embolism (PE), is a leading cause of morbidity and mortality …

Venous thromboembolism (VTE) is a multifactorial disease, and its risk depends on
exposure to risk factors and predisposing conditions. Based on their strength of association …

Unprovoked Venous Thromboembolism - Medical Clinics Skip to Main Content
Advertisement Medical Clinics Log in Register Log in Subscribe Claim Skip menu theclinics.com …

Background The optimal dose of apixaban therapy to prevent asecondary venous
thromboembolism (VTE) event remains unconfirmed. To investigate the effects of extended …

Background Patients with venous thromboembolism (VTE) are commonly classified by the
presence or absence of provoking factors at the time of VTE to guide treatment decisions …

Background Residual perfusion defects (RPD) after pulmonary embolism (PE) are common.
Primary aim This study aimed to determine the prevalence of RPD in a cohort diagnosed …